{
    "organizations": [],
    "uuid": "814c71453f438290524dcce9a6235be8faee72e0",
    "author": "",
    "url": "https://uk.reuters.com/video/2018/04/17/sanofi-in-talks-to-sell-generics-arm-for?videoId=418635755",
    "ord_in_thread": 0,
    "title": "Sanofi in talks to sell generics arm for $2.4 bln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Sanofi in talks to sell generics arm for $2.4 bln 2:40pm BST - 00:57 \nFrench healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion). Sonia Legg reports.   \nFrench healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion). Sonia Legg reports.  //reut.rs/2HG36EV",
    "published": "2018-04-17T16:40:00.000+03:00",
    "crawled": "2018-04-17T19:12:33.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "sanofi",
        "talk",
        "sell",
        "generic",
        "arm",
        "bln",
        "bst",
        "french",
        "healthcare",
        "group",
        "sanofi",
        "exclusive",
        "talk",
        "sell",
        "zentiva",
        "european",
        "generic",
        "drug",
        "arm",
        "private",
        "equity",
        "firm",
        "advent",
        "international",
        "billion",
        "euro",
        "billion",
        "sonia",
        "legg",
        "report",
        "french",
        "healthcare",
        "group",
        "sanofi",
        "exclusive",
        "talk",
        "sell",
        "zentiva",
        "european",
        "generic",
        "drug",
        "arm",
        "private",
        "equity",
        "firm",
        "advent",
        "international",
        "billion",
        "euro",
        "billion",
        "sonia",
        "legg",
        "report"
    ]
}